Imunon
Price & Volume
Stats
See more52W Range | $0.64-$3.65 |
Market Cap | $15.4M |
Shares Short | 997,876 |
Financials
See moreRevenue (12 Mos) | $125,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$1.6M |
Diluted EPS | -$1.62 |
News
See moreYahoo Finance • 10 days ago
IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
Yahoo Finance • last month
IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study
Yahoo Finance • last month
IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19
Yahoo Finance • last month
IMUNON Announces Translational Data from Phase 1/2 OVATION 2 Study of IMNN-001 in Advanced Ovarian Cancer
About
CEO | Dr. Stacy R. Lindborg Ph.D. |
Address | 997 Lenox Drive, Lawrenceville, NJ, United States, 08648 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
